FDA NEWS

Nixing Grassley's delegate status was a poor decision - Dubuque Telegraph Herald
Gentleman that he is, Sen. Chuck Grassley is quietly accepting the Iowa Republican Party's decision to omit him from the list of delegates to its national convention. Asked if he would be going to the convention, Grassley told Iowa reporters he would
Source: www.thonline.com

ANALYSIS-US FDA caution seen with Schering drug rejection - Forbes
WASHINGTON (Reuters) - The unusual rejection of an experimental drug with unanimous support from outside experts signals further caution by the U.S. Food and Drug Administration and increased uncertainty for investors. The FDA's surprising refusal
Source: www.forbes.com

Senators prod FDA to raise standards on sunscreen - CNN Money
NEW YORK (Associated Press) - A pair of powerful Democratic senators are prodding the Food and Drug Administration to release tougher standards for sunscreen labels that have been in the works for 30 years. A bill introduced Friday by Sens
Source: money.cnn.com

Senators prod FDA to toughen standards on sunscreen labels - Maryland Daily Record
Two powerful Democratic senators are prodding the Food and Drug Administration to release tougher standards for sunscreen labels that have been in the works for 30 years. A bill introduced Friday by Sens. Christopher Dodd and Jack Reed would force
Source: www.mddailyrecord.com

FDA rejects Schering-Plough's anesthesia-reversing drug, citing - Baltimore Sun
WASHINGTON (AP) _ Government regulators dealt a major setback to Schering-Plough Corp., rejecting a highly anticipated drug designed to help patients recover from anesthesia. The Food and Drug Administration notified the company Thursday that it will
Source: www.baltimoresun.com

FDA rejects Schering drug to reverse anesthesia - Forbes
Government regulators dealt a major setback to Schering-Plough Corp., rejecting a highly anticipated drug designed to help patients recover from anesthesia. The Food and Drug Administration notified the company Thursday that it will not approve its
Source: www.forbes.com

CORRECTED:House asks FDA to turn over Vytorin study analysis:WSJ - Reuters UK
NEW YORK (Reuters) - The House Energy and Commerce committee wants the U.S. Food and Drug Administration to turn over the results of an analysis about the potential links between cancer and cholesterol drug Vytorin, the Wall Street Journal reported
Source: uk.reuters.com

FDA requests additional study on Pozen drug - Boston Globe
CHAPEL HILL, N.C.— Drug developer Pozen Inc. said Friday federal regulators have requested an additional study of its experimental heart treatment before considering it for approval. Shares of Pozen Inc. fell on the news, dropping 46 cents, or 3.8
Source: www.boston.com

3 partygoers missing after early morning fire destroys house in - Minneapolis Star Tribune
Anglican leader urges ban on gay bishops School bully problem? Send in the clown Some see red over proposed 'green' resort in Maine Bikers down to bare basics for eco demonstration Daschle criticizes FBI's handling of anthrax probe LITTLETON, Colo
Source: www.startribune.com